Full Text View
Tabular View
Study Results
Related Studies
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
This study has been completed.
Study NCT00352612   Information provided by Johns Hopkins University

First Received on July 13, 2006.   Last Updated on April 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcal Infection
Abscess
Staphylococcal Skin Infection
Folliculitis
Additional conditions recognized in this trial
Skin Diseases, Infectious
Staphylococcal Infections
Staphylococcal Skin Infections
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Hair Diseases
Infection
Inflammation
Pathologic Processes
Skin Diseases
Skin Diseases, Bacterial
Suppuration
Interventions listed in this trial
clindamycin
cephalexin
Additional drug interventions recognized in this trial
Clindamycin-2-phosphate
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Aaron Chen
Thrasher Research Fund
Johns Hopkins University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services